University of California, San Diego

University / College


Location: La Jolla, CA, United States (USA) (US) US

ISNI: 0000000121074242

ROR: https://ror.org/0168r3w48

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

A review of solar forecasting, its dependence on atmospheric sciences and implications for grid integration: Towards carbon neutrality (2022) Yang D, Wang W, Gueymard CA, Hong T, Kleissl J, Huang J, Perez MJ, et al. Journal article, Review article Efficient and Easy Conversion of Human iPSCs into Functional Induced Microglia-like Cells (2022) Lanfer J, Winner B, Kaindl J, Krumm L, Acera MG, Neurath M, Regensburger M, Krach F Journal article, Review article Tuning Spin-Orbit Torques Across the Phase Transition in VO2/NiFe Heterostructure (2022) Kim JY, Cramer J, Lee K, Han DS, Go D, Salev P, Lapa PN, et al. Journal article Letter regarding “diagnosis and treatment of arterial hypertension 2021” (2022) Ix JH, Tomson CR, Cheung AK, Mann J, Cushman WC, Cheung M, Chang TI Journal article The EXO-200 detector, part II: Auxiliary systems (2022) Ackerman N, Albert J, Auger M, Auty DJ, Badhrees I, Barbeau PS, Bartoszek L, et al. Journal article Common Genetic Variants Contribute to Risk of Transposition of the Great Arteries (2022) Skoric-Milosavljevic D, Tadros R, Bosada FM, Tessadori F, Van Weerd JH, Woudstra O, Tjong FVY, et al. Journal article Symmetric correspondences with decomposable minimal equation (2022) Izadi E, Lange H Journal article Enhancing untargeted metabolomics using metadata-based source annotation. (2022) Gauglitz JM, West KA, Bittremieux W, Williams CL, Weldon KC, Panitchpakdi M, Di Ottavio F, et al. Journal article Etrolizumab as induction and maintenance therapy in patients with moderately to severely active Crohn's disease (BERGAMOT): a randomised, placebo-controlled, double-blind, phase 3 trial (2022) Sandborn WJ, Panés J, Danese S, Sharafali Z, Hassanali A, Jacob-Moffatt R, Eden C, et al. Journal article CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease (2022) Ma C, Hanzel J, Panaccione R, Sandborn WJ, D'Haens GR, Ahuja V, Atreya R, et al. Journal article